2019 Opium (Opioid) Addiction Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

February 2019 | 123 pages | ID: 27362FEDAD9EN
VPAResearch

Abstracts

The ongoing clinical trial research report- “2019 Opium (Opioid) Addiction Ongoing Clinical Trials Study” analyzes the current scenario of all active Opium (Opioid) Addiction trials across the world. The report presents top level analysis of global Opium (Opioid) Addiction clinical trials across countries, companies and universities. It is designed to provide clear understanding into the Opium (Opioid) Addiction trials landscape to assist users for effective long term strategy formulation to beat competition.

The report covers a key snapshot of ongoing trial count, average enrollment per trial across countries.

It also segments the Opium (Opioid) Addiction clinical trials by-

• Region (Asia Pacific, Europe, Middle East Africa and Americas)
• Countries
• Trial Phase
• Current Trial Status (Recruiting, Active, Planned, Active but Completed Recruiting, Not Yet Recruiting etc)
• Type of the trial (Interventional, Observational)
• Sponsor Type (Companies, Universities, Government Bodies etc)
• Enrollment across types, sponsor types, geographies, current status and phases

The report also identifies the potential drug candidates under development for treatment of Opium (Opioid) Addiction on the basis of intervention type ongoing Opium (Opioid) Addiction trials.

The research work is prepared through extensive and continuous research on Opium (Opioid) Addiction trials from over 150 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

REPORT SCOPE AND COVERAGE:

• All major ongoing trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Opium (Opioid) Addiction patients are identified
• The report includes panorama of ongoing Opium (Opioid) Addiction clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Opium (Opioid) Addiction clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Opium (Opioid) Addiction Ongoing Clinical Trials Overview, 2019
2.2 Premium Insights into Ongoing Clinical Trials
  2.2.1 Ongoing Opium (Opioid) Addiction Clinical Trials by Region
  2.2.2 Average Enrollment of Opium (Opioid) Addiction Clinical Trials
  2.2.3 Companies participating in Ongoing Trials
  2.2.4 Drugs under Study for Opium (Opioid) Addiction Treatment, 2019

3. REGION WISE OPIUM (OPIOID) ADDICTION CLINICAL TRIALS

3.1 Asia Pacific Opium (Opioid) Addiction Clinical Trials by Country
3.2 Europe Opium (Opioid) Addiction Clinical Trials by Country
3.3 North America Opium (Opioid) Addiction Clinical Trials by Country
3.4 Middle East and Africa Opium (Opioid) Addiction Clinical Trials by Country
3.5 South and Central America Opium (Opioid) Addiction Clinical Trials by Country

4. OPIUM (OPIOID) ADDICTION CLINICAL TRIAL TRENDS

4.1 Start Year wise Ongoing Opium (Opioid) Addiction Clinical Trials
4.2 Phase wise Ongoing Opium (Opioid) Addiction Clinical Trials
4.3 Trial Status wise Ongoing Opium (Opioid) Addiction Clinical Trials
4.4 Trial Type wise Ongoing Opium (Opioid) Addiction Clinical Trials

5. OPIUM (OPIOID) ADDICTION AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Opium (Opioid) Addiction Trials by Year
5.2 Average Enrollment in Opium (Opioid) Addiction Trials by Phase
5.3 Average Enrollment in Opium (Opioid) Addiction Trials by Status
5.4 Average Enrollment in Opium (Opioid) Addiction Trials by Type of Trial

6. COMPANIES PARTICIPATING IN ONGOING OPIUM (OPIOID) ADDICTION CLINICAL TRIALS

6.1 Ongoing Opium (Opioid) Addiction Trials by Sponsor Type
6.2 Opium (Opioid) Addiction Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Ongoing Opium (Opioid) Addiction Trials- Phase
7.2 Ongoing Opium (Opioid) Addiction Trials- Phase
7.3 Ongoing Opium (Opioid) Addiction Trials- Phase
7.4 Ongoing Opium (Opioid) Addiction Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Opium (Opioid) Addiction Ongoing Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Ongoing Opium (Opioid) Addiction Clinical Trials and Enrolment
Figure 5: Europe – Country wise Ongoing Opium (Opioid) Addiction Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Ongoing Opium (Opioid) Addiction Clinical Trials and Enrolment
Figure 7: North America – Country wise Ongoing Opium (Opioid) Addiction Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Ongoing Opium (Opioid) Addiction Clinical Trials and Enrolment
Figure 9: Opium (Opioid) Addiction Ongoing Clinical Trials by Phase
Figure 10: Opium (Opioid) Addiction Ongoing Clinical Trials by Trial Status
Figure 11: Opium (Opioid) Addiction Ongoing Clinical Trials by Type
Figure 12: Opium (Opioid) Addiction Ongoing Clinical Trials by Sponsor Type
Figure 13: Opium (Opioid) Addiction Ongoing Clinical Trials by Leading Sponsors
Figure 14: Opium (Opioid) Addiction Average Enrollment by Phase
Figure 15: Opium (Opioid) Addiction Average Enrollment by Trial Status
Figure 16: Opium (Opioid) Addiction Average Enrollment by Type
Figure 17: Opium (Opioid) Addiction- Average Enrolment by Type of Sponsors
Figure 18: Opium (Opioid) Addiction- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Opium (Opioid) Addiction Ongoing Clinical Trials Snapshot- 2019
Table 2: Ongoing Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Ongoing Opium (Opioid) Addiction Clinical Trials and Enrolment
Table 5: Europe – Country wise Ongoing Opium (Opioid) Addiction Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Ongoing Opium (Opioid) Addiction Clinical Trials and Enrolment
Table 7: North America – Country wise Ongoing Opium (Opioid) Addiction Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Ongoing Opium (Opioid) Addiction Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Opium (Opioid) Addiction Average Enrollment by Phase
Table 15: Opium (Opioid) Addiction Average Enrollment by Trial Status
Table 16: Opium (Opioid) Addiction Average Enrollment by Type
Table 17: Opium (Opioid) Addiction- Average Enrolment by Type of Sponsors
Table 18: Opium (Opioid) Addiction- Enrolment by Leading Sponsors